In other studies, ATF4 expression was found to sustain the aggressiveness of primary brain tumors by enhancing growth, angiogenesis, migration, and anchorage-independent cell growth and also by conferring a multidrug-resistance phenotype, whereas ATF4 knockdown reduced the malignancy features in human glioma cells [299]. The gene discussed is ATF4; the disease is central nervous system cancer.